Earnings Alerts

China Petroleum & Chemical (386) Earnings: Sinopec Shanghai’s FY IFRS Loss Misses Estimates

  • Sinopec Shanghai reported an IFRS loss of 1.35 billion yuan, missing estimates which projected a profit of 37.2 million yuan.
  • The company also reported a net loss of 1.41 billion yuan.
  • Despite the losses, Sinopec Shanghai’s revenue increased by 13% year on year, totalling 93.01 billion yuan.
  • The loss per share stands at 13 RMB cents.
  • The current market sentiment towards the company is mixed, with 5 buys, 3 holds, and 1 sell.
  • The comparisons to past results are based on values reported by the company’s original disclosures.

A look at China Petroleum & Chemical Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE4.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Petroleum & Chemical Corporation, also known as Sinopec, is a major player in the production and trading of petroleum and petrochemical products. With a strong Smartkarma Smart Score of 4 out of 5, the company’s long-term outlook is looking positive across the board.

Scoring a perfect 5 for both value and dividend, China Petroleum & Chemical is a great choice for investors looking for a solid return on their investment. Additionally, the company scores a 4 for growth, indicating potential for future expansion and development. While resilience is slightly lower at 3, the company’s momentum score of 5 suggests a strong upward trend in performance. With its wide range of products and strong presence in the Chinese market, China Petroleum & Chemical is a company to keep an eye on for long-term growth and stability.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars